<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04746014</url>
  </required_header>
  <id_info>
    <org_study_id>PROTOCOL-1133</org_study_id>
    <nct_id>NCT04746014</nct_id>
  </id_info>
  <brief_title>Clearblue Pregnancy Test Lay User Usage Study</brief_title>
  <official_title>Clearblue Pregnancy Test Lay User Usage Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SPD Development Company Limited</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>WCCT Global</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>SPD Development Company Limited</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Clearblue home pregnancy test (HPT) is an over the counter urine hCG (human chorionic&#xD;
      gonadotrophin) visual pregnancy test which is intended for the detection of pregnancy. This&#xD;
      study will assess the performance of the HPT in the hands of the lay user by comparing their&#xD;
      results when used according to the instructions for use (IFU) to (i) confirmed pregnancy&#xD;
      status of the volunteers and (ii) to the results of trained study staff testing the same&#xD;
      urine samples.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Clearblue HPT is an over the counter urine hCG visual-read test which is intended for the&#xD;
      detection of pregnancy. This study aims to demonstrate that the pregnancy test has the&#xD;
      required performance characteristics in lay user testing. The study will recruit a&#xD;
      cross-section of the target pregnancy test user population, that is, women aged over 18 years&#xD;
      representative of the intended user.&#xD;
&#xD;
      A minimum of 300 women will be required to complete the study consisting of both pregnant and&#xD;
      not pregnant volunteers. Each volunteer will conduct the pregnancy test using their preferred&#xD;
      sampling method (either 'in-stream' or 'dip'). Volunteers will be evaluated against confirmed&#xD;
      pregnancy status. Lay user comprehension of the device instructions and usability of the&#xD;
      device will also be assessed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 9, 2021</start_date>
  <completion_date type="Actual">August 3, 2021</completion_date>
  <primary_completion_date type="Actual">August 3, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of Clearblue Pregnancy Test</measure>
    <time_frame>3 days</time_frame>
    <description>Number of pregnancy tests in agreement with pregnancy status</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Co-ordinator Agreement</measure>
    <time_frame>1 day</time_frame>
    <description>Number of lay users who record the same pregnancy test result as a trained study co-ordinator</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comprehension of Instructions for Use</measure>
    <time_frame>1 day</time_frame>
    <description>Number of volunteers who answer each comprehension question correctly</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Device Usability</measure>
    <time_frame>1 day</time_frame>
    <description>Number of volunteers who record the device as easy to use</description>
  </secondary_outcome>
  <enrollment type="Actual">306</enrollment>
  <condition>Pregnancy</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Clearblue Pregnancy Test</intervention_name>
    <description>Urine Pregnancy Test</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urine and serum samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy pregnant or not pregnant volunteers requiring or wishing to conduct a pregnancy&#xD;
        test to determine or confirm pregnancy status.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female&#xD;
&#xD;
          -  Aged 18 and over&#xD;
&#xD;
          -  Interested in conducting a personal pregnancy test to determine or confirm their&#xD;
             pregnancy status&#xD;
&#xD;
          -  Willing to reveal their pregnancy status&#xD;
&#xD;
          -  Willing to provide a blood sample&#xD;
&#xD;
          -  Willing to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Significant affiliation with SPD&#xD;
&#xD;
          -  Used the investigational pregnancy test previously&#xD;
&#xD;
          -  Qualified or trainee healthcare professional (HCP)&#xD;
&#xD;
          -  Has professional experience (in current or previous job) of using dipstick type tests&#xD;
             or lateral flow devices&#xD;
&#xD;
          -  Confirmed to be pregnant by a healthcare professional and beyond the first trimester&#xD;
             (defined as last menstrual period (LMP) +13 weeks)&#xD;
&#xD;
          -  Has a medical condition that means that it is not appropriate to give a blood sample&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female only</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Johnson, PhD</last_name>
    <role>Study Director</role>
    <affiliation>SPD Development Company</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>WCCT</name>
      <address>
        <city>Cypress</city>
        <state>California</state>
        <zip>90630</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>February 4, 2021</study_first_submitted>
  <study_first_submitted_qc>February 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 9, 2021</study_first_posted>
  <last_update_submitted>August 5, 2021</last_update_submitted>
  <last_update_submitted_qc>August 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lay User</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

